Drug profile · INN
mexiletine hcl
NAMUSCLA
mexiletine hcl (NAMUSCLA) is a sodium channel alpha subunit blocker.
EMA: approved Cardiovascular system (C01) C01BB02
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — mexiletine hcl
- Class
- Cardiovascular system (C01)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
mexiletine hcl (NAMUSCLA) is a sodium channel alpha subunit blocker.
Key facts
INN mexiletine hcl
Brand NAMUSCLA
Mechanism Sodium channel alpha subunit blocker
Target Sodium channel alpha subunit
Therapeutic class Cardiovascular system (C01)
ATC code C01BB02
Mechanism of action
Sodium channel alpha subunit blocker
Primary target: Sodium channel alpha subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is mexiletine hcl?
mexiletine hcl (NAMUSCLA) is a sodium channel alpha subunit blocker.
What is the brand name for mexiletine hcl?
NAMUSCLA is a marketed brand name for mexiletine hcl. Check FDA Drugs@FDA for the current US label holder and prescribing information.